Idiopathic Pulmonary Fibrosis
📧 Sign up to get email alerts when something new happens for Idiopathic Pulmonary Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-08-20Clinical Trial Update: The Assessment of Nutritional Status of Patients With IPF [NA]
The clinical trial assessed the nutritional status of patients with idiopathic pulmonary fibrosis and has completed.
-
CLINICAL_TRIALS trial_result · 2024-08-12Clinical Trial Update: Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) [Phase 3]
Phase 3 study evaluating pamrevlumab for idiopathic pulmonary fibrosis has been terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-07-31Clinical Trial Update: Investigating Trends in Quality of Life in Patients With Idiopathic Pulmonary Fibrosis (IPF) Under Treatment With Nintedanib
Completed clinical trial evaluating trends in quality of life for patients with idiopathic pulmonary fibrosis treated with nintedanib; resul…
-
CLINICAL_TRIALS trial_result · 2024-07-26Clinical Trial Update: Efficacy of Steroid Pulse Therapy in Acute Exacerbation of Idiopathic Pulmonary Fibrosis (AE-IPF) Admitted in ER [NA]
A completed clinical trial evaluating the efficacy of steroid pulse therapy for acute exacerbation of idiopathic pulmonary fibrosis.
-
CLINICAL_TRIALS trial_result · 2024-07-09Clinical Trial Update: The Effect of N115 on Coughing in IPF Patients [Phase 3]
Phase 3 trial of N115 in idiopathic pulmonary fibrosis patients has completed and results have been posted. The study evaluates the effect o…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-07-08Clinical Trial Update: A Study to Evaluate Safety, Tolerability and Pharmacokinetics of RSN0402 in Healthy Volunteers [Phase 1]
Phase 1 trial to evaluate safety, tolerability, and pharmacokinetics of RSN0402 in healthy volunteers is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-07-08Clinical Trial Update: Treatment of Idiopathic Pulmonary Fibrosis (IPF) by REGEND001 [Phase 1]
A Phase 1 trial evaluating REGEND001 for idiopathic pulmonary fibrosis has completed; the update confirms completion of the study but does n…
-
CLINICAL_TRIALS trial_result · 2024-05-22Clinical Trial Update: A Study to Test the Efficacy and Safety of Inhaled GB0139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
Phase 2 trial of inhaled GB0139 in idiopathic pulmonary fibrosis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: A Study to Evaluate Long Term Safety and Efficacy of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis [Phase 3]
Phase 3 trial evaluating long-term safety and efficacy of PRM-151 (rhPTX-2) for idiopathic pulmonary fibrosis was terminated, and results ha…
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Assess the Safety, Tolerability and Pharmacokinetics of AZD5055 Following Single and Multiple Ascending Doses in Healthy Participants [Phase 1]
A Phase 1 study evaluated the safety, tolerability and pharmacokinetics of AZD5055 after single and multiple ascending doses in healthy part…
-
CLINICAL_TRIALS trial_result · 2024-04-30Clinical Trial Update: Evaluation of Efficacy and Safety of PLN-74809 in Patients With Idiopathic Pulmonary Fibrosis [Phase 2]
A Phase 2 study evaluating the efficacy and safety of PLN-74809 in idiopathic pulmonary fibrosis has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2024-04-19Clinical Trial Update: Adherence to Nintedanib Among Idiopathic Pulmonary Fibrosis Patients
Clinical trial update reporting adherence to nintedanib among patients with idiopathic pulmonary fibrosis.
-
CLINICAL_TRIALS trial_result · 2024-04-18Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis [Phase 3]
Phase 3 trial evaluating rhPTX-2 (PRM-151) for idiopathic pulmonary fibrosis has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2024-03-12Clinical Trial Update: Safety and Effectiveness of Nintedanib in Korean Patients
Clinical trial update on safety and effectiveness of nintedanib in Korean patients with idiopathic pulmonary fibrosis completed with results…
-
CLINICAL_TRIALS trial_result · 2024-01-16Clinical Trial Update: Telenursing and Remote Monitoring in Idiopathic Pulmonary Fibrosis (IPF) [NA]
A clinical trial update on telenursing and remote monitoring for Idiopathic Pulmonary Fibrosis has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: Phase 2a Evaluation of PLN-74809 on αvβ6 Receptor Occupancy Using PET Imaging in Participants With IPF/ [Phase 2]
Phase 2a trial evaluating PLN-74809 on αvβ6 receptor occupancy in idiopathic pulmonary fibrosis; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-12-11Clinical Trial Update: JUNIPER: A Phase 2 Study to Evaluate the Safety, Biological Activity, and PK of ND-L02-s0201 in Subjects With IPF [Phase 2]
Phase 2 trial update for ND-L02-s0201 in idiopathic pulmonary fibrosis has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: Families-At-risk for Interstitial Lung Disease Study
Completed clinical study investigating families at risk for interstitial lung disease and idiopathic pulmonary fibrosis; results posted.
-
CLINICAL_TRIALS trial_result · 2023-11-02Clinical Trial Update: A Clinical Trial on the Treatment of Idiopathic Pulmonary Fibrosis [Phase 2]
Phase 2 clinical trial update for a treatment of idiopathic pulmonary fibrosis.
-
CLINICAL_TRIALS trial_result · 2023-10-23Clinical Trial Update: Safety, Tolerability, and Pharmacokinetic Study of TRK-250 for Patients With Idiopathic Pulmonary Fibrosis [Phase 1]
Phase 1 trial assessing safety, tolerability, and pharmacokinetics of TRK-250 in idiopathic pulmonary fibrosis completed; results posted.
-
CLINICAL_TRIALS trial_result · 2023-08-31Clinical Trial Update: Clinical Efficacy and Safety of Autologous Lung Stem Cell Transplantation in Patients With Idiopathic Pulmonary Fibrosis [Phase 1, Phase 2]
Phase 1/2 trial investigating autologous lung stem cell transplantation for safety and efficacy in idiopathic pulmonary fibrosis has complet…
-
CLINICAL_TRIALS trial_result · 2023-08-31Clinical Trial Update: Nandrolone Decanoate in the Treatment of Telomeropathies [Phase 1, Phase 2]
Phase 1/2 clinical trial of nandrolone decanoate for telomeropathies, including aplastic anemia and bone marrow failure syndromes, has compl…
-
CLINICAL_TRIALS trial_result · 2023-06-28Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Idiopathic Pulmonary Fibrosis [Phase 2]
Phase 2 trial evaluating CC-90001 for idiopathic pulmonary fibrosis was terminated; no results indicate efficacy or safety outcomes were pos…
-
CLINICAL_TRIALS trial_result · 2023-06-27Clinical Trial Update: The NIH Exercise Therapy for Advanced Lung Disease Trials: Response and Adaptation to Aerobic Exercise in Patients With Interstitial Lung Disease [NA]
Clinical trial update on aerobic exercise therapy for patients with interstitial lung disease, including idiopathic pulmonary fibrosis, comp…
-
CLINICAL_TRIALS trial_result · 2023-04-14Clinical Trial Update: Morphine Sulfate/Placebo for the Treatment of PulmonAry Fibrosis Cough [Phase 3]
Phase 3 trial evaluating morphine sulfate vs placebo for cough in idiopathic pulmonary fibrosis has completed.